
In treating low-risk breast cancer, adding novel agents isn't always necessary, Hope S. Rugo says.

In treating low-risk breast cancer, adding novel agents isn't always necessary, Hope S. Rugo says.


Time is limited and the time for experiences with loved ones is today, writes breast cancer survivor Barbara Tako.

Every day seems to link another food or behavior to my cancer diagnosis. Those endless recommendations sometimes just minimize what I am going through. Am I wrong to say enough is enough?

Kelly Kenzik, epidemiologist at the University of Alabama at Birmingham School of Medicine, discusses racial disparities between African American and white women with breast cancer.

A male breast cancer survivor looks for answers from those who know best.


The treatment landscape for triple-negative breast cancer is shifting as findings from trials continue to be explored.

Losing breasts is often difficult for women to accept.

Moaath K. Mustafa Ali, Cleveland Clinic, discusses the effects of smoking on breast cancer survivorship.

Neratinib reduced recurrence or death for some women with breast cancer, according to five-year data from a phase 3 trial.

Cancer is a great teacher of many valuable lessons.

Olga Ivanov talks with CURE about the multiple side effects, including changes in sex drive, that happen after women have risk-reducing surgery.

Another biosimilar for Herceptin proved to have similar outcomes as the original drug for patients with breast cancer in a phase 3 trial.

A lesson in the power of graciousness for the hardheaded cancer patient.

A steroid-based mouthwash can help some women with breast cancer reduce or prevent stomatitis.

Alternative methods of fighting cancer may be found in natural supplements.

Even after the longest storm, there are moments of hope and rest.


Before cancer, two-time survivor Barbara Tako writes that she was in more of a hurry.

There are so many choices on the market to confuse us about healthy living. Let us be thankful that many products come with warning labels to alert us to potential cancer risks, even if they are sometimes so small we overlook them at first glance.

The traditional Chinese act of acupressure can reduce fatigue for survivors of breast cancer.

What if laughter really is the best medicine?

Allison W. Kurian offers insight on using multigene panel testing to discover breast and ovarian cancer risks that may have otherwise went undetected.

A phase 2 study showed that abemaciclib may be a promising option for some patients with breast cancer.